No. I don't agree. More likely the CHMP is the group that reviewed the initial request for centralized procedure. They are the group that has the expertise in that area for the EMA.
By the way, Anavex had no choice but to apply for the Centralized procedure. That is a requirement for CNS drugs.
News 
Market Data 
Discover 
